Global Enteral Feeding Formulas Market to reach USD 8.95 billion by 2027.Global Enteral Feeding Formulas Market is valued approximately at USD 5.95 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6% over the forecast period 2021-2027. Enteral feeding formulas are for the people who are not able to eat or digest normally due to a condition or injury that prevents eating a regular diet by mouth. Rising trend of preterm births is growing the demand in the market. Growing prevalence of chronic diseases such as cancer and diabetes, new product launches by private players and rising geriatric population around the world is growing the demand for eternal feeding formulas in the market. For instance, according to American Cancer Society, the number of new cancer cases in United States was 1,762,450 which was expected to reach 1.8 million in 2020. Also, in 2020, Victus, Inc. launched Abintra Care, a specialized nutrition that can support the immune system. Furthermore, technological advancements in products and growing preference for consumption of disease specific formulas are expected to fuel the growth in near future. However, lack of awareness for clinical nutrition in medical and healthcare community and complications associated with enteral feeding may hamper the growth during forecast period.

Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key region considered for the regional analysis. North America is dominating across the world in terms of revenue due to growing burden of chronic diseases such as cancer, diabetes and other neurological conditions. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to growing number of preterm birth and improvement in healthcare infrastructure.
Major market player included in this report are:

Abbott Laboratories
Danone SA
Fresenius Kabi
Nestl?(C)
Victus, Inc.
Primus Pharmaceuticals, Inc.
Meiji Holdings. Co., Ltd.
Reckitt Benckiser Group Plc.
Mead Johnson Nutrition Company
B. Braun Melsungen AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Standard formula
Disease-specific formula
By Flow Type:
Intermittent feeding flow
Continuous feeding flow
By Stage:
Adult
Pediatric
By Indication:
Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others
By End-user:
Hospitals
Homecare


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Enteral Feeding Formulas Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors